LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 243 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 4.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,423,018 | -14.5% | 57,127 | +2.9% | 0.00% | 0.0% |
| Q2 2023 | $4,001,477 | +102449.4% | 55,499 | +4.6% | 0.00% | -20.0% |
| Q1 2023 | $3,902 | +15.2% | 53,041 | +4.6% | 0.01% | 0.0% |
| Q4 2022 | $3,387 | -99.9% | 50,699 | +4.5% | 0.01% | -16.7% |
| Q3 2022 | $4,177,000 | -2.2% | 48,507 | +1.4% | 0.01% | 0.0% |
| Q2 2022 | $4,269,000 | -17.6% | 47,844 | +3.9% | 0.01% | -14.3% |
| Q1 2022 | $5,178,000 | -25.5% | 46,027 | +2.3% | 0.01% | -22.2% |
| Q4 2021 | $6,951,000 | +8.0% | 45,003 | -2.6% | 0.01% | 0.0% |
| Q3 2021 | $6,438,000 | -3.1% | 46,211 | -8.7% | 0.01% | 0.0% |
| Q2 2021 | $6,641,000 | -4.3% | 50,622 | +11.2% | 0.01% | 0.0% |
| Q1 2021 | $6,939,000 | +52.3% | 45,515 | -0.6% | 0.01% | +50.0% |
| Q4 2020 | $4,555,000 | +4.4% | 45,806 | +0.0% | 0.01% | -14.3% |
| Q3 2020 | $4,365,000 | -28.6% | 45,790 | -16.3% | 0.01% | -30.0% |
| Q2 2020 | $6,117,000 | +34.8% | 54,688 | -12.3% | 0.01% | 0.0% |
| Q1 2020 | $4,537,000 | -30.6% | 62,384 | -0.5% | 0.01% | -9.1% |
| Q4 2019 | $6,542,000 | -0.1% | 62,725 | -4.6% | 0.01% | -8.3% |
| Q3 2019 | $6,548,000 | -13.6% | 65,781 | -0.9% | 0.01% | -14.3% |
| Q2 2019 | $7,579,000 | -10.3% | 66,393 | -1.2% | 0.01% | -12.5% |
| Q1 2019 | $8,449,000 | -7.9% | 67,209 | -0.6% | 0.02% | -20.0% |
| Q4 2018 | $9,172,000 | -35.3% | 67,591 | +30.8% | 0.02% | -25.9% |
| Q3 2018 | $14,185,000 | +27.9% | 51,676 | -3.5% | 0.03% | +22.7% |
| Q2 2018 | $11,094,000 | +30.9% | 53,548 | +4.3% | 0.02% | +22.2% |
| Q1 2018 | $8,478,000 | +22.1% | 51,333 | +1.2% | 0.02% | +28.6% |
| Q4 2017 | $6,944,000 | +17.2% | 50,710 | +16.5% | 0.01% | +7.7% |
| Q3 2017 | $5,925,000 | +20.3% | 43,518 | +7.3% | 0.01% | +18.2% |
| Q2 2017 | $4,924,000 | +16.4% | 40,559 | +1.5% | 0.01% | +10.0% |
| Q1 2017 | $4,231,000 | +41.2% | 39,979 | +35.6% | 0.01% | +25.0% |
| Q4 2016 | $2,996,000 | +6.1% | 29,489 | +6.6% | 0.01% | 0.0% |
| Q3 2016 | $2,823,000 | -8.7% | 27,660 | +6.7% | 0.01% | -11.1% |
| Q2 2016 | $3,093,000 | +17.7% | 25,932 | +5.7% | 0.01% | +12.5% |
| Q1 2016 | $2,627,000 | +0.7% | 24,527 | +2.0% | 0.01% | 0.0% |
| Q4 2015 | $2,608,000 | +43.5% | 24,057 | +13.4% | 0.01% | +33.3% |
| Q3 2015 | $1,817,000 | -12.8% | 21,211 | +2.7% | 0.01% | -14.3% |
| Q2 2015 | $2,084,000 | +14.5% | 20,650 | -12.5% | 0.01% | +40.0% |
| Q1 2015 | $1,820,000 | +60.9% | 23,598 | +11.0% | 0.01% | +66.7% |
| Q4 2014 | $1,131,000 | +9.5% | 21,253 | -3.3% | 0.00% | 0.0% |
| Q3 2014 | $1,033,000 | -28.9% | 21,978 | -5.8% | 0.00% | -25.0% |
| Q2 2014 | $1,453,000 | +0.3% | 23,328 | +8.3% | 0.00% | 0.0% |
| Q1 2014 | $1,449,000 | +23.3% | 21,544 | -3.5% | 0.00% | +33.3% |
| Q4 2013 | $1,175,000 | +51.8% | 22,335 | +24.8% | 0.00% | +50.0% |
| Q3 2013 | $774,000 | +14.8% | 17,895 | -0.7% | 0.00% | 0.0% |
| Q2 2013 | $674,000 | – | 18,017 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knott David M Jr | 115,000 | $8,459 | 3.32% |
| VILLERE ST DENIS J & CO LLC | 480,807 | $35,368,162 | 2.57% |
| Chicago Capital, LLC | 449,508 | $33,065,822 | 1.64% |
| RICE HALL JAMES & ASSOCIATES, LLC | 288,345 | $21,210,681 | 1.20% |
| Smith, Graham & Co., Investment Advisors, LP | 65,163 | $4,793,390 | 0.58% |
| Stephens Investment Management Group LLC | 455,089 | $33,476,347 | 0.56% |
| CARDINAL CAPITAL MANAGEMENT LLC /CT | 201,993 | $14,858,605 | 0.53% |
| WOODSTOCK CORP | 52,604 | $3,869,550 | 0.49% |
| Court Place Advisors, LLC | 15,533 | $1,142,607 | 0.41% |
| Jackson Creek Investment Advisors LLC | 12,726 | $936 | 0.39% |